Abstract
Background
In the domain of Alzheimer’s disease (AD) prevention, various potentially protective factors have been identified in epidemiological studies. Although the results of these observational studies have been relatively consistent, the results of intervention studies remain disappointing. Methodological problems could explain these negative results, like the selection of the population; a plausible assumption is that the older people who agree to take part in these intervention studies differ from those who refuse, and are those that are least likely to benefit from such programs. The aim of this study was (i) to study the determinants of participation in and adhesion to a prevention trial in a population of older individuals via a quantitative approach using a questionnaire, (ii) to study the representations and practices of prevention in this population using a qualitative approach using semi-structured interviews and focus groups.
Method
The study population for the ACCEPT study was recruited at the time of inclusion of subjects in a prevention trial. The population was made up of persons aged 70 years or older, living at home and demonstrating some form of frailty, defined as a spontaneous memory complaint to their general practitioner or difficulties in carrying out instrumental activities of daily living. We used a quantitative approach based on the administration of a self-completed questionnaire sent to 1680 subjects having accepted to take part in the prevention trial, and to the sample of subjects meeting the inclusion criteria but having refused to take part. The qualitative approach, carried out at the moment of inclusion, involved subjects that having accepted to take part and subjects that having refused. Semi-structured interviews were carried out in order to understand the logic leading to refusal or acceptance.
Conclusion
The analysis of the results will combine the viewpoints of the different disciplines. It will allow us to better understand the logic at work, to characterise the populations at risk of refusal, and perhaps to remove some of the barriers to participation in prevention programs. The identification of such barriers will provide feedback in terms of the conception and management of prevention measures.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 2006;10(5):377–385.
Kawas CH. Medications and diet: protective factors for AD? Alzheimer Dis Assoc Disord 2006;20(3 Suppl 2):S89–S96.
Scarmeas N, Stern Y, Mayeux R, Luchsinger JA. Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 2006;63(12):1709–1717.
Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H. Walking and dementia in physically capable elderly men. Jama 2004;292(12):1447–1453.
Larson EB, Wang LI, Bowen J, Mccormick WC, Teri L, Crane P, et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 2006;144(2):73–81.
Lytle ME, Vander Bilt J, Pandav RS, Dodge HH, Ganguli M. Exercise level and cognitive decline: the MoVIES project. Alzheimer. Dis. Assoc. Disord. 2004;18(2):57–64.
Podewils LJ, Guallar E, Kuller LH, Fried LP, Lopez OL, Carlson M, et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am. J. Epidemiol. 2005;161(7):639–651.
Weuve J, Kang JH, Manson JE, Breteler MM, Ware JH, Grodstein F. Physical activity, including walking, and cognitive function in older women. Jama. 2004;292(12):1454–1461.
Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch. Intern. Med. 2001;161(14):1703–1708.
Barnes LL, Mendes De Leon CF, Wilson RS, Bienias JL, Evans DA. Social resources and cognitive decline in a population of older African Americans and whites. Neurology. 2004;63(12):2322–2326.
Holtzman RE, Rebok GW, Saczynski JS, Kouzis AC, Wilcox Doyle K, Eaton WW. Social network characteristics and cognition in middle-aged and older adults. J. Gerontol. B. Psychol. Sci. Soc. Sci. 2004;59(6):P278–P284.
Wilson RS, Mendes De Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. Jama. 2002;287(6):742–748.
Coley N, Andrieu S, Gardette V, Gillette-Guyonnet S, Sanz C, Vellas B, Grand A. Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev. 2008;30:35–66.
Saczynski JS, Pfeifer LA, Masaki K, Korf ES, Laurin D, White L, et al. The effect of social engagement on incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 2006;163(5):433–440.
Malouf R, Grimley EJ, Aerosa Sastre A. Folic acid with or without vitamin B12 for cognition and dementia (review). The Cochrane Library 2005 Issue 3.
Eussen SJ, de Groot LC, Joosten LW, Bloo RJ, Clarke R, Ueland PM, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 2006;84(2):361–370.
Campbell AJ, Robertson MC, La Grow SJ, Kerse NM, Sanderson GF, Jacobs RJ, et al. Randomised controlled trial of prevention of falls in people aged > or =75 with severe visual impairment: the VIP trial. Bmj 2005;331(7520):817.
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. Jama 2005;293(1):43–53.
Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069–1075.
Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001;153:72–78.
Vass M, Avlund K, Hendriksen C. Randomized intervention trial on preventive home visits to older people: baseline and follow-up characteristics of participants and nonparticipants. Scand J Public Health. 2007;35(4):410–417.
Ives DG, Traven ND, Kuller LH, Schulz R. Selection bias and nonresponse to health promotion in older adults. Epidemiology. 1994 Jul;5(4):456–461.
Fitzpatrick AL, Fried LP, Williamson J, Crowley P, Posey D, Kwong L, Bonk J, Moyer R, Chabot J, Kidoguchi L, Furberg CD, DeKosky ST; GEM Study Investigators. Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience. Contemp Clin Trials. 2006 Dec;27(6):541–553.
van Heuvelen MJ, Hochstenbach JB, Brouwer WH, de Greef MH, Zijlstra GA, van Jaarsveld E, Kempen GI, van Sonderen E, Ormel J, Mulder T. Differences between participants and non-participants in an RCT on physical activity and psychological interventions for older persons. Aging Clin Exp Res. 2005 Jun;17(3):236–245.
Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L, Barberger-Gateau P, Fabrigoule C, Dartigues JF. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain. 2005 May;128(Pt 5):1093–1101.
Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues Jf, Touchon J, Vellas B; MAPT STUDY GROUP. Commentary on “a roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer’s disease. Alzheimers Dement. 2009 Mar;5(2):114–121
Fearn P, Avenell A, McCann S, Milne AC, Maclennan G; MAVIS TRIAL GROUP. Factors influencing the participation of older people in clinical trials — data analysis from the MAVIS trial. J Nutr Health Aging. 2010 Jan;14(1):51–56.
Jones RW, Andrieu S, Knox S, Mackell J. Physicians and caregivers: ready and waiting for increased participation in clinical research. J Nutr Health Aging. 2010 Aug;14(7):563–568.
Author information
Authors and Affiliations
Additional information
For The Accept Study Group
Rights and permissions
About this article
Cite this article
Andrieu, S., Coley, N., Gardette, V. et al. Representations and practices of prevention in elderly populations: Investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer’s disease (accept study) — The need for a multidisciplinary approach. J Nutr Health Aging 16, 352–354 (2012). https://doi.org/10.1007/s12603-012-0045-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-012-0045-9